Wordt geladen...
PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
Programmed death-1 (PD-1) is a cell surface receptor that functions as a T cell checkpoint and plays a central role in regulating T cell exhaustion. Binding of PD-1 to its ligand, programmed death-ligand 1 (PD-L1), activates downstream signaling pathways and inhibits T cell activation. Moreover abno...
Bewaard in:
| Gepubliceerd in: | Hum Vaccin Immunother |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6605868/ https://ncbi.nlm.nih.gov/pubmed/30888929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1571892 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|